Key Finding
Combined interventions were most effective for MS fatigue, while acupuncture or massage therapy showed significant benefit with an effect size of -0.67, ranking among the top non-pharmacological treatments.
Fatigue is one of the most challenging symptoms experienced by people with multiple sclerosis (MS), significantly impacting daily activities and quality of life. Researchers conducted a comprehensive review of 73 studies to determine which non-drug treatments work best for reducing MS-related fatigue.
The study compared nine different types of non-pharmacological interventions, including exercise programs, cognitive-behavioral therapy, acupuncture or massage therapy, digital health tools (eHealth), and combinations of these approaches. All studies were analyzed together to determine which treatments showed the strongest results.
The findings revealed that several approaches effectively reduced fatigue in people with MS. Combined interventions—using multiple treatment types together—appeared to be most effective overall. Acupuncture or massage therapy showed significant benefits, with results indicating meaningful improvements in fatigue levels. Other effective options included cognitive-behavioral therapy, exercise therapy, and eHealth interventions.
For patients considering acupuncture, this research provides encouraging evidence. Acupuncture and massage therapy demonstrated effectiveness comparable to other established treatments, with statistical significance showing real improvement beyond placebo effects. The analysis suggests these hands-on therapies can serve as valuable options for managing MS fatigue, either alone or as part of a comprehensive treatment plan.
What this means for MS patients is that non-drug options, particularly acupuncture and massage, represent evidence-based choices for fatigue management. These treatments may be especially appealing for those seeking alternatives to medication or wanting to complement existing therapies. The research supports acupuncture as a legitimate intervention backed by clinical evidence, not just anecdotal reports.
Patients interested in acupuncture for MS fatigue should seek a licensed acupuncturist with experience treating neurological conditions.
This systematic review and network meta-analysis examined comparative efficacy of non-pharmacological interventions for MS-related fatigue across 73 randomized controlled trials. Quality assessment utilized Cochrane Risk of Bias Tool 2.0, with network meta-analysis performed using STATA 17.0.
Nine intervention categories were analyzed against control groups. Results demonstrated statistically significant fatigue reduction with multiple modalities: exercise therapy (SMD = -0.53, 95% CI [-0.74, -0.33]), cognitive-behavioral therapy (SMD = -0.64, 95% CI [-1.05, -0.22]), acupuncture or massage therapy (SMD = -0.67, 95% CI [-1.28, -0.06]), eHealth interventions (SMD = -0.42, 95% CI [-0.66, -0.18]), and combined interventions (SMD = -0.79, 95% CI [-1.27, -0.31]).
Combined interventions ranked highest for efficacy. Acupuncture/massage therapy showed moderate-to-large effect sizes with statistical significance, supporting their inclusion in MS fatigue management protocols.
Clinical implications: Evidence supports acupuncture and massage as effective monotherapies or adjunctive treatments for MS fatigue. Multimodal approaches demonstrate superior outcomes, suggesting integration of acupuncture within comprehensive care plans may optimize patient results.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.